Hydrogenology
Hydrogenology editorial study record

Molecular Hydrogen Positively Affects Physical and Respiratory Function in Acute Post-COVID-19 Patients

Botek M et al. · Int J Environ Res Public Health. 2022;19(4):1992.

HumanOther formsPublished 2022
Study record, not medical adviceThis page reports one source and Hydrogenology’s source-text extraction. It does not establish that molecular hydrogen is effective, safe or appropriate for any person. Human, animal and laboratory evidence must not be treated as equivalent.
Source and classification

What kind of evidence is this?

Evidence stream

Human

Reported design

Randomized single-blind placebo-controlled parallel trial

Research topic

Long COVID

Administration classification

Other forms

Study result signal

Not reported in this record.

Outcome type

Not reported in this record.

Reported in the source

Methods at a glance

Population or model

Non-hospitalized, unvaccinated adults tested 21–35 days after acute COVID-19

Sample

50 participants: 26 men and 24 women

Duration

Two 60-minute sessions daily for 14 days

Intervention

Nasal-cannula H₂ at 300 mL/min for two 60-minute home sessions daily

Hydrogen form

H₂ alone at high source-gas purity — not Brown’s gas.

H₂ specification

99.99% H₂ source-gas purity according to the generator manual.

H₂ flow

299.97 mL/min H₂, calculated as 300 mL/min source-gas flow × 99.99% H₂.

O₂ delivered with H₂

No supplemental O₂ was co-delivered; trace O₂ content was not reported.

Comparator

Ambient air from a modified generator

Reported, not endorsed

Outcomes and reported result

Outcomes measured

Six-minute walk, FVC, FEV1, oxygen saturation, dyspnea, exertion and daily symptom ratings

Reported result

Changes favored H₂ for six-minute walk distance, FVC and FEV1. Daily fatigue, sleep, muscle soreness and dyspnea ratings did not differ between groups; oxygen saturation and exertion comparisons were also null.

Results-extraction completeness

Gas purity, flow, methods, full outcome tables, funding and conflicts checked in the open-access full text; independent appraisal remains incomplete.

A reported association, difference or mechanism is not automatically a clinical benefit. Null findings, outcome type, study design and precision all matter.

Interpretation limits

Cautions and applicability

Design and reporting cautions

Single-blind, 50-person short trial with baseline BMI and body-fat imbalance and home self-administration. It concerns early post-acute recovery, not established Long COVID. Authors declared no conflicts.

Applies directly to

Clinically stable, non-hospitalized adults 21–35 days after COVID-19 under the study criteria.

Preliminary appraisal framework

Not reported in this record.

Preliminary risk-of-bias status

Not reported in this record.

Appraisal rationale

Not reported in this record.

No single-study GRADE certainty rating is assigned. Certainty is assessed by important outcome across a complete eligible evidence set, not by attaching a final grade to one source.

Provenance

Sources and record status

Identifiers

PMID: 35206179 · DOI: 10.3390/ijerph19041992

Publisher access

Open-access publisher and PMC full texts are available.

Extraction basis

Open-access PMC and publisher full texts plus PubMed bibliographic record.

Record revision

2026-08-10